Principal Financial Group
EPZM

Principal Financial Group’s Epizyme, Inc EPZM Stock Holding History

Principal Financial Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-37,606
Closed -$43K – 2710
2022
Q1 		$43K Buy
37,606
+9,809
+35% +$16K ﹤0.01% 2494
2021
Q4 		$70K Sell
27,797
-11,791
-30% -$46.3K ﹤0.01% 2466
2021
Q3 		$203K Buy
39,588
+1,735
+5% +$10.5K ﹤0.01% 2431
2021
Q2 		$314K Sell
37,853
-595
-2% -$5.02K ﹤0.01% 2343
2021
Q1 		$334K Buy
38,448
+876
+2% +$9.06K ﹤0.01% 2249
2020
Q4 		$408K Buy
37,572
+5,611
+18% +$69.2K ﹤0.01% 2168
2020
Q3 		$381K Sell
31,961
-1,956
-6% -$26.2K ﹤0.01% 2074
2020
Q2 		$544K Sell
33,917
-15,373
-31% -$268K ﹤0.01% 1949
2020
Q1 		$764K Sell
49,290
-8,398
-15% -$180K ﹤0.01% 1784
2019
Q4 		$1.42M Buy
57,688
+35,209
+157% +$523K ﹤0.01% 1779
2019
Q3 		$232K Buy
22,479
+10,310
+85% +$130K ﹤0.01% 2107
2019
Q2 		$153K Buy
12,169
+1,235
+11% +$15.9K ﹤0.01% 2163
2019
Q1 		$135K Buy
+10,934
New +$122K ﹤0.01% 2147
2018
Q4 		– Sell
-10,521
Closed -$112K – 2340
2018
Q3 		$112K Buy
10,521
+346
+3% +$3.95K ﹤0.01% 2225
2018
Q2 		$138K Sell
10,175
-333
-3% -$5.18K ﹤0.01% 2202
2018
Q1 		$187K Buy
+10,508
New +$177K ﹤0.01% 2115
2017
Q4 		– Sell
-96,248
Closed -$1.83M – 2280
2017
Q3 		$1.83M Buy
96,248
+676
+0.7% +$10.3K ﹤0.01% 1751
2017
Q2 		$1.44M Buy
95,572
+1,399
+1% +$21.1K ﹤0.01% 1787
2017
Q1 		$1.61M Buy
94,173
+515
+0.5% +$6.86K ﹤0.01% 1749
2016
Q4 		$1.13M Buy
93,658
+3,734
+4% +$39K ﹤0.01% 1796
2016
Q3 		$885K Buy
89,924
+8,746
+11% +$79.8K ﹤0.01% 1791
2016
Q2 		$831K Sell
81,178
-1,310
-2% -$14.6K ﹤0.01% 1783
2016
Q1 		$1M Sell
82,488
-691
-0.8% -$6.99K ﹤0.01% 1729
2015
Q4 		$1.33M Buy
83,179
+123
+0.1% +$1.82K ﹤0.01% 1712
2015
Q3 		$1.07M Buy
83,056
+1,293
+2% +$26.1K ﹤0.01% 1758
2015
Q2 		$1.96M Buy
81,763
+7,863
+11% +$151K ﹤0.01% 1684
2015
Q1 		$1.39M Buy
73,900
+400
+0.5% +$8.26K ﹤0.01% 1717
2014
Q4 		$1.39M Buy
73,500
+900
+1% +$21K ﹤0.01% 1747
2014
Q3 		$1.97M Sell
72,600
-1,200
-2% -$37.3K ﹤0.01% 1655
2014
Q2 		$2.3M Hold
73,800
– – ﹤0.01% 1654
2014
Q1 		$1.68M Buy
+73,800
New +$2.24M ﹤0.01% 1685
2013
Q4 		– Sell
-41,000
Closed -$1.65M – 2318
2013
Q3 		$1.65M Hold
41,000
– – ﹤0.01% 1667
2013
Q2 		$1.15M Buy
+41,000
New +$1.05M ﹤0.01% 1702

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group's EPZM Position: Q2 2022 in Review

Principal Financial Group sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 37,606 shares — an estimated $43K sold.

Principal Financial Group first reported a position in EPZM in Q2 2013 and held it in 33 quarters. The position peaked at $2.3M in Q2 2014. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Principal Financial Group reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 37,606 Epizyme, Inc shares in Q2 2022, an estimated $43K.
  • Principal Financial Group first reported a position in Epizyme, Inc in Q2 2013 and held it in 33 quarters.
  • Principal Financial Group's Epizyme, Inc position peaked at $2.3M in Q2 2014.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.